I have rich, comprehensive data from the textbooks. Now let me compile the full, well-organized answer.
Drug Classification Used in Sexually Transmitted Diseases (STDs/STIs)
Below is a systematic classification of drugs used in STI treatment, organized by drug class and by disease. Based on Harrison's Principles of Internal Medicine 22E, Tintinalli's Emergency Medicine, and Rosen's Emergency Medicine.
1. Classification by Drug Class
A. Beta-Lactam Antibiotics (Cephalosporins & Penicillins)
| Drug | Route | STI Indication |
|---|
| Ceftriaxone (3rd-gen cephalosporin) | IM (500 mg or 1g) | First-line for gonorrhea (N. gonorrhoeae); also used in chancroid, PID, gonococcal epididymitis |
| Benzathine Penicillin G | IM | First-line for all stages of syphilis (T. pallidum); 2.4 million units single dose for primary/secondary/early latent; 3 weekly doses for tertiary/late latent |
| Amoxicillin | PO | Alternative for chlamydia in pregnancy (500 mg TID x 7 days) |
Key note: Fluoroquinolones are NO longer recommended for gonorrhea due to widespread resistance. Ceftriaxone is now the sole first-line agent. - Harrison's Internal Medicine 22E
B. Macrolides
| Drug | Route/Dose | STI Indication |
|---|
| Azithromycin | 1 g PO single dose | First-line for chlamydia (C. trachomatis); alternative for gonorrhea (with ceftriaxone), chancroid; safe in pregnancy |
| Azithromycin | 2 g PO single dose | Alternative for gonorrhea |
| Erythromycin base | 500 mg PO QID x 7 days | Alternative for chlamydia |
C. Tetracyclines
| Drug | Route/Dose | STI Indication |
|---|
| Doxycycline | 100 mg PO BID x 7 days | First-line for chlamydia; used in PID (oral step-down); treatment of non-gonococcal urethritis (NGU); LGV (100 mg BID x 21 days); early syphilis (alternative if penicillin-allergic) |
| Tetracycline | 500 mg PO QID x 28 days | Alternative for syphilis in penicillin allergy |
Contraindicated in pregnancy - Rosen's Emergency Medicine
D. Nitroimidazoles
| Drug | Route/Dose | STI Indication |
|---|
| Metronidazole | 2 g PO single dose | First-line for trichomoniasis (T. vaginalis); also first-line for bacterial vaginosis (BV) (500 mg BID x 7 days or 0.75% vaginal gel x 5 days) |
| Tinidazole | 2 g PO single dose | Alternative for trichomoniasis; alternative for BV |
E. Fluoroquinolones
| Drug | Route/Dose | STI Indication |
|---|
| Ciprofloxacin | 500 mg PO single dose x 3 days | Used in chancroid (H. ducreyi); NOT used for gonorrhea anymore |
| Ofloxacin / Levofloxacin | PO | Alternative agents in PID (in penicillin-allergic patients) |
Note: Fluoroquinolones are contraindicated in pregnancy. - Rosen's Emergency Medicine
F. Lincosamides
| Drug | Route/Dose | STI Indication |
|---|
| Clindamycin | 300 mg PO BID x 7 days | Alternative for bacterial vaginosis; component of PID regimens (900 mg IV) |
| Clindamycin vaginal cream 2% | 5 g intravaginally x 7 days | First-line alternative for BV |
G. Antivirals
| Drug | Route/Dose | STI Indication |
|---|
| Acyclovir | 400 mg PO TID x 7-10 days | First-line for primary genital herpes (HSV-1/2); suppressive therapy (400 mg BID) |
| Valacyclovir | 1 g PO BID x 7-10 days | First-line for primary genital herpes; suppressive therapy (500 mg OD) |
| Famciclovir | 250 mg PO TID x 7-10 days | Alternative for genital herpes |
H. Antiretrovirals (HIV)
| Drug Class | Examples | Use |
|---|
| NRTIs | Tenofovir, Emtricitabine (TDF/FTC) | HIV treatment (first-line backbone); PrEP (pre-exposure prophylaxis) |
| NNRTIs | Efavirenz, Rilpivirine | Combined with NRTI backbone |
| Integrase Inhibitors | Dolutegravir, Bictegravir | Preferred third agents in current HIV regimens |
| Protease Inhibitors | Darunavir | Used in ART |
| Entry Inhibitors | Cabotegravir (injectable) | Long-acting PrEP |
I. Topical / Local Agents
| Drug | Form | STI Indication |
|---|
| Podophyllin / Podophyllotoxin | Topical solution | Genital warts (HPV) - provider-applied |
| Imiquimod 5% | Topical cream | Genital warts (HPV) - patient-applied; immune modulator |
| Trichloroacetic acid (TCA) | Chemical | Wart ablation |
| Clotrimazole / Fluconazole | Topical/oral | Vulvovaginal candidiasis |
2. Classification by Disease (Quick Reference)
| STD | First-Line Drug(s) | Drug Class |
|---|
| Gonorrhea | Ceftriaxone 500 mg IM (single dose) | 3rd-gen cephalosporin |
| Chlamydia | Doxycycline 100 mg BID x 7 days | Tetracycline |
| Syphilis | Benzathine Penicillin G 2.4 MU IM | Beta-lactam |
| Genital Herpes | Acyclovir / Valacyclovir | Antiviral (nucleoside analogue) |
| Trichomoniasis | Metronidazole 2 g PO single dose | Nitroimidazole |
| Bacterial Vaginosis | Metronidazole 500 mg BID x 7 days | Nitroimidazole |
| Chancroid | Azithromycin 1 g PO or Ceftriaxone 250 mg IM | Macrolide / Cephalosporin |
| LGV (C. trachomatis) | Doxycycline 100 mg BID x 21 days | Tetracycline |
| Donovanosis | Azithromycin 1 g/week OR Doxycycline | Macrolide / Tetracycline |
| HPV / Warts | Imiquimod (topical), Podophyllin | Immune modulator / Antimitotic |
| Candidiasis | Fluconazole 150 mg PO single dose | Azole antifungal |
| HIV | TDF/FTC + Dolutegravir (ART) | Antiretrovirals |
| PID | Ceftriaxone + Doxycycline ± Metronidazole | Combination |
3. Special Considerations
Pregnancy:
- Safe: Azithromycin, Amoxicillin, Cephalosporins, Acyclovir, Metronidazole (all trimesters), Penicillin
- Avoid: Tetracyclines (doxycycline), Fluoroquinolones - Rosen's Emergency Medicine
Dual therapy (gonorrhea + chlamydia):
Since co-infection is common (~30-40%), when treating gonorrhea with ceftriaxone, always cover chlamydia concurrently with doxycycline or azithromycin. - Tintinalli's Emergency Medicine
Penicillin allergy and syphilis:
Doxycycline 100 mg BID x 14 days is the alternative; desensitization to penicillin is preferred in pregnancy since no proven equivalent exists.
Drug resistance:
- Gonorrhea has acquired resistance to fluoroquinolones, older penicillins, and even azithromycin (monotherapy)
- Metronidazole resistance in T. vaginalis is increasingly reported; use higher-dose tinidazole as alternative
- Ceftriaxone remains the last reliable oral single-dose agent for gonorrhea
Sources: Harrison's Principles of Internal Medicine 22E (2025), Tintinalli's Emergency Medicine, Rosen's Emergency Medicine - Concepts and Clinical Practice